Hologic, Inc. Hologic, Inc.

Hologic, Inc.

HOLX

Ранг среди акций #1328
Hologic, Inc. is a medical technology company focused on designing, producing,... Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
Цена акции
$76.01
Последняя синхронизация: 2026-04-07
Рыночная капитализация
$16.97B
Изменение (1 день)
0.00%
Изменение (1 год)
2.74%
Страна
US
Торговля Hologic, Inc. (HOLX)

Категория

Healthcare
Количество находящихся в обращении акций Hologic, Inc. (HOLX)
Количество акций в обращении на December 2025: 224.41M
Согласно последним финансовым отчетам и цене акций Hologic, Inc., текущее количество акций в обращении составляет 224.41M. На конец September 2024 у компании было 235.72M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Hologic, Inc. (HOLX) с 2000 по 2026
Акции в обращении на конец каждого года
Год Акции в обращении Изменить
2026 (TTM) 224.41M -1.23%
2025 227.19M -3.62%
2024 235.72M -4.48%
2023 246.77M -1.89%
2022 251.53M -2.15%
2021 257.05M -2.16%
2020 262.73M -2.48%
2019 269.41M -2.07%
2018 275.11M -1.68%
2017 279.81M -0.14%
2016 280.21M -0.13%
2015 280.57M 1.84%
2014 275.50M 2.53%
2013 268.70M 2.22%
2012 262.86M 0.67%
2011 261.10M 0.91%
2010 258.74M 0.86%
2009 256.55M 4.30%
2008 245.97M 130.15%
2007 106.87M 14.89%
2006 93.02M 8.61%
2005 85.65M 5.70%
2004 81.03M 3.20%
2003 78.52M 6.57%
2002 73.68M 19.03%
2001 61.90M 1.01%
2000 61.28M 0.00%
Акции в обращении у аналогичных компаний или конкурентов
Компания Акции в обращении Разница Страна
354.50M 57.97%
US
461.20M 105.52%
FR
- -
JP
274.79M 22.45%
US
- -
CH